Domiciliary treatment of febrile episodes in cancer patients: A prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment

Supportive Care in Cancer

Volumn 7, Issue 3, 1999, Pages 134-139

  Minotti, V ^a   Gentile, G ^b   Bucaneve, G ^a   Iori, A P ^b   Micozzi, A ^b   Cavicchi, F ^a   Barbabietola, G ^a   Landonio, G ^c   Menichetti, F ^a   Martino, P ^b   Del Favero, A ^a  

^a POLICLINICO MONTELUCE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Falk Division of Medical Oncology   (Italy)

Author keywords

Cancer; Fever; Outpatient antibiotic therapy

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEBRILE NEUTROPENIA; FEMALE; HOME CARE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEFTRIAXONE; CEPHALOSPORINS; CIPROFLOXACIN; FEMALE; FEVER; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; OUTPATIENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032943889     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050243     Document Type: Article

References (18)

1. Baumgartner JD, Glauser MP (1983) Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment. Arch Intern Med 143:1868-1873
2. Bodey GP (1986) Infection in cancer patients. A continuing association. Am J Med 81:11-26
3. Bodey GP (1993) Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 17:5378-5384
4. Bucaneve G, Menichetti F, Minotti V, et al (1989) Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients. Chemotherapy 35:10-15
5. Chanock S (1993) Evolving risk factors for infections complications of cancer therapy. Hematol Oncol Clin North Am 7:771-793
6. Hussain M, Kish JA, Crane L, et al (1991) The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. Cancer 67:716-721
7. Malik IA, Abbas Z, Karim M (1992) Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients. Lancet 339:1092-1096
8. Malik IA, Khan WA, Karim M, et al (1995) Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 98:224-231
9. Menichetti F, Del Favero A, Bucaneve G, et al (1990) Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts. Infection 18:166-169
10. Pizzo PA (1990) Empirical therapy and prevention of infection in the immunocompromised host. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 2303-2312
11. Putinati S, Trevisani L, Gualandi M, et al (1994) Pulmonary infections in lung cancer patients at diagnosis. Lung Cancer 11:243-249
12. Rodary C, Corn Nougue C, Tournade MF (1989) How to establish equivalence between treatments: a one-sided clinical trial in pediatric oncology. Stat Med 8:593-598
13. Rolston KV, Haron E, Cunningham C, et al (1989) Intravenous ciprofloxacin for infections in cancer patients. Am J Med 87:261-265
14. Rolston KV, Jones PG, Fainstein V, et al (1991) Single agent therapy for infections in cancer patients : a prospective randomized trial comparing three extended-spectrum cephalosporins. Eur J Clin Microbiol Infect Dis 10:139-145
15. Rolston KV, Rubenstein EB, Elting LS, et al (1995) Ambulatory management of febrile episodes in low-risk neutropenic patients (abstract LM38). Programs and proceedings of the 35th Interscience Conference on Antimicrobial Agents in Chemotherapy, San Francisco, 17-20.9.95
16. Rubinstein EB, Rolston K, Benjamin RS, et al (1993) Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71:3640-3646
17. Talcott JA, Siegel RD, Finberg R, et al (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322
18. Talcott JA, Whalen A, Clark J, et al (1994) Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 12:107-114